No featured image available
Americans’ satisfaction with the U.S. rollout of the coronavirus vaccines surged to 68% in the past month, a Tuesday Gallup poll shows.
The satisfaction rate is 24 points higher than February and double the rate in January, when just over one-third of Americans approved of the rollout. The amount of Americans willing to receive the vaccine increased to 74%, rising three points since February.
A majority of Americans across the political spectrum were satisfied with the rollout, the poll showed, with 73% of Democrats, 66% of Republicans and 63% of Independents approving. In January, just 22%, 49% and 37% said that they approved respectively.
The vaccine’s rising approval mirrors the increasing vaccination rate seen across the country. The U.S. has averaged well-over two-million shots per day, according to the Centers for Disease Control, up from 1.5 million a month ago.
President Joe Biden set a goal of 200 million shots administered in before the end of April during his press conference Thursday, double the original target.
Adult Americans of all ages also said they were satisfied with the U.S. rollout thus far. Among seniors, who are the most susceptible to COVID-19 and whose vaccinations have been prioritized, approval stood at 77%.
Among those who said they were still hesitant to receive the vaccines, 23% said they wanted to wait until its safety was confirmed and 20% said that they did not think COVID-19 carried serious health effects. Smaller groups said that they were concerned about how quickly it was developed or that they generally distrusted vaccines.
The Gallup poll surveyed 3,905 American adults from March 15-21, and has a margin of error of two points.
All content created by the Daily Caller News Foundation, an independent and nonpartisan newswire service, is available without charge to any legitimate news publisher that can provide a large audience. All republished articles must include our logo, our reporter’s byline and their DCNF affiliation. For any questions about our guidelines or partnering with us, please contact [email protected].